Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to introduce ...
Catalyst MedTech's Full Access Neurology solution is designed to operationalize Brain PET at scale--enabling neurology practices, health systems, imaging providers, and clinical research sites to ...
Phase 2b data show RAD101 amino acid PET hits 90% concordance, helping distinguish brain metastasis recurrence from ...
Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that ...
With a simple brain scan, providers can now better detect and monitor Alzheimer’s disease. Dr. Tracy Vargas, a neurologist at ...
At the Yale Positron Emission Tomography (PET) Center, an ultra-high-performance brain-dedicated scanner called the NeuroEXPLORER (NX) is redefining what is possible in brain PET imaging. Subscribe to ...
PET tracer ACI-19626 safely detects toxic TDP-43 protein clumps in the brain. TDP-43 clumps are a hallmark in 97% of ALS ...
Algernon Health (CSE:AGN, OTCQB:AGNPF, FRA:AGW0) on Wednesday announced “NovaScan Neuroimaging Clinics” as the new brand name ...
Tau proteins play an important role in Alzheimer's disease. Tau helps to stabilize neurons in the brain, but in Alzheimer's disease, tau proteins can misfold and tangle inside neurons. These tangles ...
PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results